Does Rallies show Form 4 insider transactions for ENTA?

Yes. Rallies tracks ENTA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ENTA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENTA. It does not provide personalized investment advice.

ENTA (Enanta Pharmaceuticals, Inc) Stock Analysis - Insider Trades

Enanta Pharmaceuticals, Inc (ENTA) is a publicly traded Healthcare sector company. As of May 21, 2026, ENTA trades at $9.48 with a market cap of $391.10M and a P/E ratio of -5.28. ENTA moved -0.87% today. Year to date, ENTA is -2.16%; over the trailing twelve months it is +124.22%. Its 52-week range spans $4.09 to $17.15. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces ENTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ENTA stock inside the company?

Recent ENTA insider activity includes Capps Kathleen S. sold 323, Trout Harry R. III sold 542, Rottinghaus Scott T. sold 798, Luu Brendan sold 1.39K, and Kieffer Tara Lynn sold 2.11K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ENTA Key Metrics

Key financial metrics for ENTA
Metric	Value
Price	$9.48
Market Cap	$391.10M
P/E Ratio	-5.28
EPS	$-2.60
Dividend Yield	0.00%
52-Week High	$17.15
52-Week Low	$4.09
Volume	2
Avg Volume	0
Revenue (TTM)	$69.21M
Net Income	$-61.98M
Gross Margin	0.00%

Recent ENTA Insider Trades

Capps Kathleen S. sold 323 (~$4.60K) on Dec 5, 2025.
Trout Harry R. III sold 542 (~$7.71K) on Dec 5, 2025.
Rottinghaus Scott T. sold 798 (~$11.36K) on Dec 5, 2025.
Luu Brendan sold 1.39K (~$19.84K) on Dec 5, 2025.
Kieffer Tara Lynn sold 2.11K (~$29.97K) on Dec 5, 2025.

Latest ENTA News

Enanta Pharmaceuticals Posts Q2 Loss of $0.45, Shares Jump 5.3% — May 11, 2026
Enanta to Present Phase 2b RSV Trial Showing One-Week Symptom Reduction and Resistance Barrier — Apr 7, 2026
Enanta Posts Q1 $0.42 Loss per Share, Beats Revenue by 19.5% — Feb 9, 2026

ENTA Analyst Consensus

3 analysts cover ENTA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.

Common questions about ENTA

Who is trading ENTA stock inside the company?: Recent ENTA insider activity includes Capps Kathleen S. sold 323, Trout Harry R. III sold 542, Rottinghaus Scott T. sold 798, Luu Brendan sold 1.39K, and Kieffer Tara Lynn sold 2.11K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ENTA?: Yes. Rallies tracks ENTA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ENTA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENTA. It does not provide personalized investment advice.